Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78

Cancer Research

Volumn 65, Issue 11, 2005, Pages 4663-4672

  Davidson, Don J ^a   Haskell, Catherine ^a   Majest, Sandy ^a   Kherzai, Abdullah ^a   Egan, David A ^a   Walter, Karl A ^a   Schneider, Andrew ^a   Gubbins, Earl F ^a   Solomon, Larry ^a   Chen, Zhebo ^a   Lesniewski, Rick ^a   Henkin, Jack ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 7; GLUCOSE REGULATED PROTEIN 78; PLASMINOGEN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING SITE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; FIBROSARCOMA; HUMAN; HUMAN CELL; KRINGLE DOMAIN; PRIORITY JOURNAL; PROTEIN BINDING; STRESS; TUMOR CELL;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; APOPTOSIS; BINDING SITES; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; ENDOTHELIAL CELLS; FIBROSARCOMA; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMINOGEN; PROTEIN BINDING; RECOMBINANT PROTEINS;

EID: 21144441659     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3426     Document Type: Article

References (36)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
2. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985; 43:175-203.
3. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (London) 1992; 359:843-5.
4. Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent J Biol Chem 1996;271:603-6.
5. Wang Y, Becker D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med 1997;3:887-93.
6. Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 1997;22:251-6.
7. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285:245-8.
8. Jimenez B, Volpert OV. Mechanistic insights on the inhibition of tumor angiogenesis. J Mol Med 2001;78: 663-72.
9. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:149-53.
10. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
11. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994;265:1582-4.
12. Fang J, Yan L, Shing Y, Moses MA. HIF-1a-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res 2001;61:5731-5.
13. Sage EH. Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell Biol 1997;7:182-6.
14. Browder T, Folkman J, Pirie-Shepard S. The hemostatic system as a regulator of angiogenesis. J Biol Chem 2000;275:1521-4.
15. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-28.
16. Cao Y, Ji R, Davidson D, et al. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem 1996;271:29461-7.
17. Castellino FJ, McCance SG. The kringle domains of human plasminogen. Ciba Found Symp 1997;212:46-60.
18. Cao Y, Chen A, An SSA, et al. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem 1997;272:22924-8.
19. Lu H, Dhanabal M, Volk R, et al. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells. Biochem Biophys Res Commun 1999;258:668-73.
20. Ji WR, Barrientos LG, Llinas M, et al. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem Biophys Res Commun 1998;247: 414-9.
21. Zhang D, Kaufman PL, Gao G, Saunders RA, Ma JX. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats. Diabetologia 2001;44:757-65.
22. Chang Y, Mochalkin I, McCance SG, Cheng B, Tulinsky A, Castellino FJ. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen. Biochemistry 1998; 37:3258-71.
23. Bush GA, Yoshida N, Lively MO, et al. Ion beam tritium labeling of proteins and peptides. J Biol Chem 1981;256:12213-21.
24. Markwell MAK. A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Anal Biochem 1982;125:427-32.
25. Frevert CW, Wong VA, Goodman RB, Goodwin R, Martin TR Rapid fluorescence-based measurement of neutrophil migration in vitro. J Immunol Methods 1998;213:41-52.
26. Polverini PJ, Bouck NP, Rastinejad F. Assay and purification of naturally occurring inhibitor of angiogenesis. Methods Enzymol 1991;198:440-50.
27. Mayr M, Li C, Zou Y, Huemer U, Hu Y, Xu Q. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J 2000;14:261-70.
28. Dudani AK, Ganz PR. Endothelial cell surface actin serves as a binding site for plasminogen. tissue plasminogen activator and lipoprotein(a). Br J Haematol 1996;95:168-78.
29. Zhang JC, Donate F, Qi X, et al. The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin. Proc Natl Acad Sci U S A 2002;99:12224-9.
30. Kariv I, Cao H, Oldenburg KR. Development of a high throughput equilibrium dialysis method. J Pharm Sci 2001;90:580-7.
31. Spangnolo R, Corada FO, Zanetta L, et al. Gas 1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis. Blood 2004;8:3005-12.
32. Koomagi R, Mattern J, Volm M. Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angioge nesis in non-small cell lung carcinomas. Anticancer Res 1999;19:4333-6.
33. Gonzalez-Gronow M, Kalfa T, Johnson CE, Gawdi G, Pizzo SV. The voltage-dependent anion channel is a receptor for plasminogen kringle 5 on human endothelial cells. J Biol Chem 2003;278:27312-8.
34. Schwarzer C, Barnikol-Watanabe S, Thinnes FP, Hilschmann N. Voltage-dependent anion-selective channel (VDAC) interacts with the dynein light chain Tctexl and the heat-shock protein PBP74. Int J Biochem Cell Biol 2002;34:1059-70.
35. Namiki A, Brogi E, Kearney M, et al. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 1995;270:31189-95.
36. Reddy RK, Mao C, Baumeister P, Austin RC, Kaufman RJ, Lee AS. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem 2003; 278:20915-24.